Multicenter phase III study of antimicrobial prophylaxis in low-risk patients undergoing distal gastrectomy for gastric cancer (OGSG 0501)

Multicenter phase III study of antimicrobial prophylaxis in low-risk patients undergoing distal gastrectomy for gastric cancer (OGSG 0501) - OGSG-0501

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000000631

Enrollment

342

Registered

2007-04-01

Start date

2005-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

distal gastrectomy for gastric cancer

Interventions

Group A: AMP is administered before and during surgical operation and SSI is detected after surgery. Group B: AMP is administered before, during and after surgical operation and SSI is detected after

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.age not limmited. 2.histologically proven gastric cancer 3.ASA score of 1 or 2 4.completion of written informed consent 5.distal gastrectomy with D2 lymphadenectomy and clean-contaminated operation

Exclusion criteria

Exclusion criteria: 1.with some active or uncontrolled infection 2.neoadjuvant chemotherapy 3.PS>3 in ASA 4.administration of steroids 5.decision of ineligible patients by the researcher

Design outcomes

Primary

Measure	Time frame
Incidence of SSI	—

Countries

Japan

Contacts

Public ContactHiroshi Imamura

Toyonaka City Hospital Dpt.Surgery

imamurahiroshisakai@yahoo.co.jp06-6843-0101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026